Hugel Inc (145020) - Total Liabilities

Latest as of March 2026: ₩99.59 Billion KRW ≈ $67.49 Million USD

Based on the latest financial reports, Hugel Inc (145020) has total liabilities worth ₩99.59 Billion KRW (≈ $67.49 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Hugel Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how Hugel Inc's total liabilities have evolved over time, based on quarterly financial data. See 145020 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Hugel Inc Competitors by Total Liabilities

The table below lists competitors of Hugel Inc ranked by their total liabilities.

Company Country Total Liabilities
Westshore Terminals Investment Corp
TO:WTE
Canada CA$1.85 Billion
Omnicell Inc
NASDAQ:OMCL
USA $742.91 Million
Guangdong Advertising Co Ltd
SHE:002400
China CN¥7.50 Billion
Dalian Zeus Entertainment
SHE:002354
China CN¥648.57 Million
Megaport Ltd
AU:MP1
Australia AU$437.11 Million
BIEM.L .FDLKK Garment Co Ltd
SHE:002832
China CN¥2.22 Billion
Fagron NV
BR:FAGR
Belgium €686.87 Million
4iG Nyrt.
BUD:4IG
Hungary Ft1.24 Trillion

Liability Composition Analysis (2014–2025)

This chart breaks down Hugel Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Hugel Inc.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 7.49 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.10 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.09 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hugel Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hugel Inc (2014–2025)

The table below shows the annual total liabilities of Hugel Inc from 2014 to 2025.

Year Total Liabilities Change
2025-12-31 ₩96.68 Billion
≈ $65.52 Million
-1.98%
2024-12-31 ₩98.63 Billion
≈ $66.84 Million
-34.06%
2023-12-31 ₩149.57 Billion
≈ $101.36 Million
-41.95%
2022-12-31 ₩257.67 Billion
≈ $174.62 Million
+10.75%
2021-12-31 ₩232.65 Billion
≈ $157.66 Million
+10.96%
2020-12-31 ₩209.67 Billion
≈ $142.09 Million
+7.42%
2019-12-31 ₩195.19 Billion
≈ $132.28 Million
+2.44%
2018-12-31 ₩190.55 Billion
≈ $129.13 Million
+52.17%
2017-12-31 ₩125.22 Billion
≈ $84.86 Million
+201.71%
2016-12-31 ₩41.50 Billion
≈ $28.13 Million
+61.33%
2015-12-31 ₩25.73 Billion
≈ $17.43 Million
-41.58%
2014-12-31 ₩44.04 Billion
≈ $29.84 Million
--

About Hugel Inc

KQ:145020 Korea Biotechnology
Market Cap
$1.82 Billion
₩2.68 Trillion KRW
Market Cap Rank
#6633 Global
#172 in Korea
Share Price
₩248000.00
Change (1 day)
+1.43%
52-Week Range
₩214000.00 - ₩388000.00
All Time High
₩388000.00
About

Hugel, Inc. develops and manufactures biopharmaceuticals in South Korea and internationally. The company offers Botulinum Toxin, a white injectable dry powder in a transparent glass vial for use in the treatment of positive essential eyelid convulsion in adults over 18 years of age; improvement of severe lasso wrinkles associated with corrugator muscles and/or procerus muscle activities in adults… Read more